Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries

We are analyzing https://link.springer.com/article/10.1186/s12950-019-0216-0.

Title:
Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1 | Journal of Inflammation
Description:
Background Radiation-induced lung fibrosis (RILF) is a severe and life-threatening complication of thoracic radiotherapy. Cell death is the key issue in RILF. Ferroptosis is a form programmed cell death implicated in the pathologies of inflammation. This study aimed to investigate the role of ferroptosis in RILF, and the effectiveness and the potential underlying mechanism of ferroptosis inhibitor on RILF. Methods Immunofluorescence, western blot and RT-PCR assays were performed to examine the ferroptosis maker glutathione peroxidase 4 (GPX4) in a mice RILF model. The lung tissue sections were stained with hematoxylin and eosin (H&E), Masson trichrome staining and Sirius-Red staining to evaluate the histopathological changes in RILF mice. Reactive oxygen species (ROS) and hydroxyproline (HYP) in lungs were measured by the relevant kits. The serum levels of inflammatory cytokines (TNF-α, IL-6, IL-10, and TGF-β1) were measured with Elisa. The protein and mRNA levels of GPX4, nuclear factor (erythroid-derived 2)-like 2 (Nrf2), hemeoxygenase-1 (HO1) and quinone oxidoreductase 1 (NQO1) in lungs were examined by western blot and RT-PCR. Results GPX4 levels of the irradiated lungs were significantly down-regulated than the groups with no irradiation, and the ferroptosis inhibitor, liproxstatin-1, increased GPX4 levels significantly in RILF mice. Treatment with liproxstatin-1 lowered the Szapiel and Ashcroft scores significantly, down-regulated the levels of ROS and HYP in lungs and reduced the serum inflammatory cytokines levels in RILF mice. The protein and the mRNA levels of Nrf2, HO1 and NQO1 were up-regulated by liproxsratin-1 in RILF. Conclusions Our data suggested that ferroptosis played a critical role in RILF, ferroptosis inhibitor liproxstatin-1 alleviated RILF via down-regulation of TGF-β1 by the activation of Nrf2 pathway. The effectiveness of ferroptosis inhibition on RILF provides a novel therapeutic target for RILF.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

rilf, ferroptosis, nrf, article, lung, google, scholar, ros, gpx, mice, fig, inhibitor, levels, fibrosis, radiation, tgfβ, liproxstatin, cell, cas, pathway, inflammatory, data, role, lungs, analysis, staining, cytokines, injury, radiationinduced, signaling, results, death, significantly, china, study, nqo, pulmonary, oxidative, hyp, cells, content, inflammation, activation, cancer, induced, damage, shown, min, irradiated, effects,

Topics {✒️}

p62-keap1-nrf2 pathway protects tgf-β/smad3 signaling pathway age-related renal fibrosis radiation-induced lung injury transforming growth factor-β1 radiation-induced oxidative damage retro-ocular artery blood including glutathione s-transferases paraquat-induced ferroptosis leading friedmann angeli jp measure necrosis factor-α ros-induced oxidative damage article  google scholar enzyme-linked immunosorbent assay tgf-β1/smad signaling grant number jskj-ktqn-2017-01 anti-fade mounting medium small-cell lung cancer article download pdf related subjects epithelial-mesenchymal transition fluorescence-labeled secondary antibodies evaluate ir-induced fibrosis oxidative stress-inducible genes regulating tgf-β1 expression radiation therapy-assessment radiation-induced cytochrome full access ferroptosis inhibitor induced reactive oxygen species pulmonary fibrosis mediated radiation-induced expression gpx4 inhibition-induced ferroptosis pro-inflammatory cytokines il-6 inflammatory cytokines induced left lung specimens real time pcr thoracic radiation injury lung tissue samples initial radiation therapy ferroptosis inhibitor activated privacy choices/manage cookies ischemia-reperfusion injury ischemia-reperfusion injury [12 lipid repair enzyme creative commons license damaged lung tissue induce pulmonary injury cell mol med hepatocellular carcinoma cell

Questions {❓}

  • Inhibition of radiation-induced oxidative damage in the lung tissue: may acetylsalicylic acid have a positive role?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1
         description:Radiation-induced lung fibrosis (RILF) is a severe and life-threatening complication of thoracic radiotherapy. Cell death is the key issue in RILF. Ferroptosis is a form programmed cell death implicated in the pathologies of inflammation. This study aimed to investigate the role of ferroptosis in RILF, and the effectiveness and the potential underlying mechanism of ferroptosis inhibitor on RILF. Immunofluorescence, western blot and RT-PCR assays were performed to examine the ferroptosis maker glutathione peroxidase 4 (GPX4) in a mice RILF model. The lung tissue sections were stained with hematoxylin and eosin (H&E), Masson trichrome staining and Sirius-Red staining to evaluate the histopathological changes in RILF mice. Reactive oxygen species (ROS) and hydroxyproline (HYP) in lungs were measured by the relevant kits. The serum levels of inflammatory cytokines (TNF-α, IL-6, IL-10, and TGF-β1) were measured with Elisa. The protein and mRNA levels of GPX4, nuclear factor (erythroid-derived 2)-like 2 (Nrf2), hemeoxygenase-1 (HO1) and quinone oxidoreductase 1 (NQO1) in lungs were examined by western blot and RT-PCR. GPX4 levels of the irradiated lungs were significantly down-regulated than the groups with no irradiation, and the ferroptosis inhibitor, liproxstatin-1, increased GPX4 levels significantly in RILF mice. Treatment with liproxstatin-1 lowered the Szapiel and Ashcroft scores significantly, down-regulated the levels of ROS and HYP in lungs and reduced the serum inflammatory cytokines levels in RILF mice. The protein and the mRNA levels of Nrf2, HO1 and NQO1 were up-regulated by liproxsratin-1 in RILF. Our data suggested that ferroptosis played a critical role in RILF, ferroptosis inhibitor liproxstatin-1 alleviated RILF via down-regulation of TGF-β1 by the activation of Nrf2 pathway. The effectiveness of ferroptosis inhibition on RILF provides a novel therapeutic target for RILF.
         datePublished:2019-05-29T00:00:00Z
         dateModified:2019-05-29T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12950-019-0216-0
         keywords:
            Radiation-induced lung fibrosis
            Ferroptosis
            Ferroptosis inhibitor
            TGF-β1
            ROS
            Nrf2
            Immunology
            Allergology
            Cytokines and Growth Factors
            Rheumatology
            Pharmacology/Toxicology
            Gastroenterology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig7_HTML.png
         isPartOf:
            name:Journal of Inflammation
            issn:
               1476-9255
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Xuan Li
               affiliation:
                     name:Zhongshan Hospital, Fudan University
                     address:
                        name:Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Jinshan Hospital, Fudan University
                     address:
                        name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lijie Duan
               affiliation:
                     name:Jinshan Hospital, Fudan University
                     address:
                        name:Department of Neurology, Jinshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sujuan Yuan
               affiliation:
                     name:Jinshan Hospital, Fudan University
                     address:
                        name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xibing Zhuang
               affiliation:
                     name:Jinshan Hospital, Fudan University
                     address:
                        name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tiankui Qiao
               affiliation:
                     name:Jinshan Hospital, Fudan University
                     address:
                        name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jian He
               url:http://orcid.org/0000-0002-1198-8267
               affiliation:
                     name:Zhongshan Hospital, Fudan University
                     address:
                        name:Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1
      description:Radiation-induced lung fibrosis (RILF) is a severe and life-threatening complication of thoracic radiotherapy. Cell death is the key issue in RILF. Ferroptosis is a form programmed cell death implicated in the pathologies of inflammation. This study aimed to investigate the role of ferroptosis in RILF, and the effectiveness and the potential underlying mechanism of ferroptosis inhibitor on RILF. Immunofluorescence, western blot and RT-PCR assays were performed to examine the ferroptosis maker glutathione peroxidase 4 (GPX4) in a mice RILF model. The lung tissue sections were stained with hematoxylin and eosin (H&E), Masson trichrome staining and Sirius-Red staining to evaluate the histopathological changes in RILF mice. Reactive oxygen species (ROS) and hydroxyproline (HYP) in lungs were measured by the relevant kits. The serum levels of inflammatory cytokines (TNF-α, IL-6, IL-10, and TGF-β1) were measured with Elisa. The protein and mRNA levels of GPX4, nuclear factor (erythroid-derived 2)-like 2 (Nrf2), hemeoxygenase-1 (HO1) and quinone oxidoreductase 1 (NQO1) in lungs were examined by western blot and RT-PCR. GPX4 levels of the irradiated lungs were significantly down-regulated than the groups with no irradiation, and the ferroptosis inhibitor, liproxstatin-1, increased GPX4 levels significantly in RILF mice. Treatment with liproxstatin-1 lowered the Szapiel and Ashcroft scores significantly, down-regulated the levels of ROS and HYP in lungs and reduced the serum inflammatory cytokines levels in RILF mice. The protein and the mRNA levels of Nrf2, HO1 and NQO1 were up-regulated by liproxsratin-1 in RILF. Our data suggested that ferroptosis played a critical role in RILF, ferroptosis inhibitor liproxstatin-1 alleviated RILF via down-regulation of TGF-β1 by the activation of Nrf2 pathway. The effectiveness of ferroptosis inhibition on RILF provides a novel therapeutic target for RILF.
      datePublished:2019-05-29T00:00:00Z
      dateModified:2019-05-29T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12950-019-0216-0
      keywords:
         Radiation-induced lung fibrosis
         Ferroptosis
         Ferroptosis inhibitor
         TGF-β1
         ROS
         Nrf2
         Immunology
         Allergology
         Cytokines and Growth Factors
         Rheumatology
         Pharmacology/Toxicology
         Gastroenterology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12950-019-0216-0/MediaObjects/12950_2019_216_Fig7_HTML.png
      isPartOf:
         name:Journal of Inflammation
         issn:
            1476-9255
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Xuan Li
            affiliation:
                  name:Zhongshan Hospital, Fudan University
                  address:
                     name:Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Jinshan Hospital, Fudan University
                  address:
                     name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lijie Duan
            affiliation:
                  name:Jinshan Hospital, Fudan University
                  address:
                     name:Department of Neurology, Jinshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sujuan Yuan
            affiliation:
                  name:Jinshan Hospital, Fudan University
                  address:
                     name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xibing Zhuang
            affiliation:
                  name:Jinshan Hospital, Fudan University
                  address:
                     name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tiankui Qiao
            affiliation:
                  name:Jinshan Hospital, Fudan University
                  address:
                     name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jian He
            url:http://orcid.org/0000-0002-1198-8267
            affiliation:
                  name:Zhongshan Hospital, Fudan University
                  address:
                     name:Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Inflammation
      issn:
         1476-9255
      volumeNumber:16
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Zhongshan Hospital, Fudan University
      address:
         name:Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Jinshan Hospital, Fudan University
      address:
         name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Jinshan Hospital, Fudan University
      address:
         name:Department of Neurology, Jinshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Jinshan Hospital, Fudan University
      address:
         name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Jinshan Hospital, Fudan University
      address:
         name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Jinshan Hospital, Fudan University
      address:
         name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Zhongshan Hospital, Fudan University
      address:
         name:Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Xuan Li
      affiliation:
            name:Zhongshan Hospital, Fudan University
            address:
               name:Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Jinshan Hospital, Fudan University
            address:
               name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Lijie Duan
      affiliation:
            name:Jinshan Hospital, Fudan University
            address:
               name:Department of Neurology, Jinshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Sujuan Yuan
      affiliation:
            name:Jinshan Hospital, Fudan University
            address:
               name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Xibing Zhuang
      affiliation:
            name:Jinshan Hospital, Fudan University
            address:
               name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Tiankui Qiao
      affiliation:
            name:Jinshan Hospital, Fudan University
            address:
               name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jian He
      url:http://orcid.org/0000-0002-1198-8267
      affiliation:
            name:Zhongshan Hospital, Fudan University
            address:
               name:Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
      name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
      name:Department of Neurology, Jinshan Hospital, Fudan University, Shanghai, China
      name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
      name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
      name:Department of Radiation Oncology, Jinshan Hospital, Fudan University, Shanghai, China
      name:Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China

External Links {🔗}(115)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

5.14s.